Glepaglutide (ZP1848), a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide reduces faecal output and increases intestinal absorption. Glepaglutide alleviates small intestinal inflammation. Glepaglutide can be used in the research of inflammatory bowel disease (IBD) and Crohns disease[1][2][3].
Molecular Weight:
4316.08
Purity:
99.53
CAS Number:
[914009-86-2]
Formula:
C197H325N53O55
Target:
GCGR
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
